| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ZEVRA THERAPEUTICS, INC. | Chief Scientific Officer | Restricted Stock Unit | 79,000 | $391,769 | $4.96 | 31 Jan 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ZVRA | ZEVRA THERAPEUTICS, INC. | 31 Jan 2024 | 1 | $0 | 4 | Chief Scientific Officer | 02 Feb 2024, 20:13 |
| ZVRA | KEMPHARM, INC | 09 Jan 2023 | 1 | $0 | 4 | Chief Scientific Officer | 11 Jan 2023, 20:50 |
| ZVRA | KEMPHARM, INC | 01 Feb 2022 | 1 | $0 | 4 | EVP, Research & Development | 03 Feb 2022, 16:17 |
| ZVRA | KEMPHARM, INC | 20 Aug 2021 | 1 | $0 | 4 | EVP, Research & Development | 24 Aug 2021, 16:26 |